NUTRIBAND INC (NTRB) Stock News
NASDAQ:NTRB - Nasdaq - US67092M2089 - Common Stock - Currency: USD
NTRB Latest News, Press Releases and Analysis
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
These stocks are moving in today's session
The trading volume of these stocks is deviating from the norm in today's session.
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
Nutriband Issues Letter to Shareholders
Nutriband Issues Letter to Shareholders
CEO Publishes Letter to Shareholders looking over achievements in 2024 and outlook for 2025...
Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology
Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology
Chinese Patent for AVERSA extended to Macao...
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025
Nutriband Inc. Q3 report and highlights...
Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th
Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th
Serguei Melnik will present at the Noble Conference to discuss the companies latest advances with its AVERSA technology ...
Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology
AVERSA Fentanyl has the potential to be the world's first and only abuse-deterrent opioid patch
Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology
Nutriband Inc receives Hong Kong Patent Notice of Publication for its AVERSA patent application bringing the total number of countries covered to 46...
Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica
Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse
EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:NTRBW),(NYSE:TEVA),(NYSE:LLY),(NYSE:NVS),(NASDAQ:AMRX) EQNX::TICKER_END
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse
NUTRIBAND RECEIVES CHINA PATENT NOTICE OF ALLOWANCE FOR ITS AVERSA™ ABUSE DETERRENT TRANSDERMAL TECHNOLOGY
Notice of Allowance received from Chinese National Intellectual Property Administration (CNIPA) for a patent application covering its Nutriband AVERSA™ abuse deterrent transdermal technology Nutriband abuse-deterrent transdermal technology consists of a proprietary aversive agent coating that employs taste aversion to deter the oral abuse of and accidental exposure to transdermal opioid and stimulant patch products […]
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Inks Licensing Agreement to Use Bitrex(R) Aversive Agent for Flagship Product
Nutriband (NASDAQ: NTRB), a company engaged in the development of prescription transdermal pharmaceutical products, has signed a trademark licensing agreement for the use of Bitrex(R) brand denatonium benzoate. According to the announcement, Bitrex is the most bitter substance in the world, and Nutriband will be using it as an aversive agent in its lead product, […]
Nutriband Inc. Authorizes $1M Share Buyback Program
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Releases Q2 Report, AVERSA Fentanyl Update
Nutriband (NASDAQ: NTRB), a developer of transdermal pharmaceutical products, is reporting its Q2 2024 financial results for the period ending July 31, 2024. According to the report, the company ended the quarter in a strong cash position, reinforcing its ability to advance the development of its lead product, AVERSA(TM) Fentanyl, with a New Drug Application […]
Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25
NTRB Stock Earnings: Nutriband Reported Results for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Nutriband (NASDAQ:NTRB) just reported results for the first quarter of 2024.Nut...
NTRB Stock Earnings: Nutriband Reported Results for Q1 2024
Nutriband just reported results for the first quarter of 2024.
Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl
Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors
NTRB Stock Earnings: Nutriband Reported Results for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Nutriband (NASDAQ:NTRB) just reported results for the fourth quarter of 2023.Nu...
NTRB Stock Earnings: Nutriband Reported Results for Q4 2023
Nutriband just reported results for the fourth quarter of 2023.